Bridgeway Capital Management’s Edwards Lifesciences EW Stock Holding History

Bridgeway Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-32,400	Closed	-$2.59M	–	1321
2020 Q3	$2.59M	Hold	32,400	–	–	0.06%	338
2020 Q2	$2.24M	Sell	32,400 -27,000	-45%	-$1.92M	0.05%	381
2020 Q1	$3.73M	Hold	59,400	–	–	0.09%	193
2019 Q4	$4.62M	Buy	+59,400	New	+$4.64M	0.06%	267
2017 Q2	–	Sell	-249,000	Closed	-$7.81M	–	1433
2017 Q1	$7.81M	Sell	249,000 -65,400	-21%	-$2.05M	0.09%	168
2016 Q4	$9.82M	Hold	314,400	–	–	0.13%	148
2016 Q3	$12.6M	Sell	314,400 -93,000	-23%	-$3.5M	0.19%	133
2016 Q2	$13.5M	Buy	407,400 +28,800	+8%	+$985K	0.21%	135
2016 Q1	$11.1M	Hold	378,600	–	–	0.19%	144
2015 Q4	$9.97M	Hold	378,600	–	–	0.19%	140
2015 Q3	$8.97M	Buy	378,600 +184,800	+95%	+$4.46M	0.19%	145
2015 Q2	$4.6M	Hold	193,800	–	–	0.09%	241
2015 Q1	$4.6M	Hold	193,800	–	–	0.1%	234
2014 Q4	$4.11M	Hold	193,800	–	–	0.09%	235
2014 Q3	$3.3M	Buy	+193,800	New	+$3.06M	0.08%	283

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bridgeway Capital Management's EW Position: Q4 2020 in Review

Bridgeway Capital Management sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 32,400 shares — an estimated $2.59M sold.

Bridgeway Capital Management first reported a position in EW in Q3 2014 and held it in 15 quarters. The position peaked at $13.5M in Q2 2016. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.

Bridgeway Capital Management reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
Bridgeway Capital Management sold 32,400 Edwards Lifesciences shares in Q4 2020, an estimated $2.59M.
Bridgeway Capital Management first reported a position in Edwards Lifesciences in Q3 2014 and held it in 15 quarters.
Bridgeway Capital Management's Edwards Lifesciences position peaked at $13.5M in Q2 2016.
1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Bridgeway Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.